News & Updates

Show Multimedia Only
Calcium-channel blocker use ups glaucoma prevalence

Calcium-channel blocker use ups glaucoma prevalence

26 Sep 2023 byStephen Padilla

Use of calcium-channel blockers (CCBs) appears to increase the risk of developing glaucoma, suggests a study. In addition, use of systemic beta blockers is associated with lower intraocular pressure (IOP).

26 Sep 2023
Otilimab for RA disappoints in ContRAst 3

Otilimab for RA disappoints in ContRAst 3

25 Sep 2023

In the treatment of select patients with rheumatoid arthritis (RA), otilimab is neither better than placebo nor noninferior to sarilumab in terms of the proportion of patients achieving an American College of Rheumatology ≥20 percent response (ACR20), according to the results of the phase III ContRAst 3 study.

25 Sep 2023